Genzyme backs support effort for MS patients

Share this article:
Genzyme backs support effort for MS patients
Genzyme backs support effort for MS patients

The lives of five patients with mutiple sclerosis will be chronicled online as part of a program developed by the National MS Society and Sanofi's Genzyme unit. The program, called Everyday Matters, chose the patients from a pool of 1,200 entries to receive individual support as they share experiences.

Organizers say they will seek to engage those living with or affected by MS by tapping into  positive psychology, drawing on the achievements of the patients to help inspire others. Patients will be tracked through personal text, video, and photo journals, all to be showcased on the website everydayMSmatters.org.

The patients—including a school teacher and single mom—will focus on the top five aspects of life, as identified by MS patients in a June 2012 poll by the society: wellness, work/education, relationships, family and empowerment. Emmy-winning producer Kristen Adams, herself an individual living with MS, will help film the stories. A life coach who also has MS, Michelle Clos, will provide one-on-one coaching, and best-selling author of The Happiness Advantage, Shawn Achor, will guide efforts.

“I know first-hand that ‘staying positive' can become that much more challenging after being diagnosed with a chronic and unpredictable disease like MS,” Clos said in a statement.

In June Genzyme submitted Lemtrada (alemtuzumab), for relapsing MS treatment, to the FDA and European regulators. An annual injection, the drug would compete against MS treatments like Novartis' Gilenya (fingolimod), Teva's Copaxone (glatiramer) and Biogen-Idec's Tysabri (natalizumab).
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.